loadpatents
name:-0.020425081253052
name:-0.011884927749634
name:-0.00075197219848633
Elliott; Gary S. Patent Filings

Elliott; Gary S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Elliott; Gary S..The latest application filed is for "methods of selecting epidermal growth factor receptor (egfr) binding agents".

Company Profile
0.8.18
  • Elliott; Gary S. - Thousand Oaks CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods of selecting epidermal growth factor receptor (EGFr) binding agents
Grant 9,097,729 - Freeman , et al. August 4, 2
2015-08-04
Methods Of Selecting Epidermal Growth Factor Receptor (egfr) Binding Agents
App 20150051091 - Freeman; Daniel J. ;   et al.
2015-02-19
Methods Of Treatment Using Il-17e Antagonists
App 20140037635 - MEDLOCK; Eugene ;   et al.
2014-02-06
Methods of selecting epidermal growth factor receptor (EGFR) binding agents
Grant 7,985,559 - Freeman , et al. July 26, 2
2011-07-26
Il-17 Receptor Like Molecules And Uses Thereof
App 20110160438 - Medlock; Eugene ;   et al.
2011-06-30
IL-17 receptor like molecules and uses thereof
Grant 7,943,738 - Medlock , et al. May 17, 2
2011-05-17
Methods Of Treatment Using Il-17e Antagonists
App 20100303820 - Medlock; Eugene ;   et al.
2010-12-02
IL-17 receptor like molecules and uses thereof
App 20090281287 - Medlock; Eugene ;   et al.
2009-11-12
IL-receptor like molecules and uses thereof
Grant 7,611,857 - Medlock , et al. November 3, 2
2009-11-03
IL-17 like molecules and uses thereof
App 20070123459 - Medlock; Eugene ;   et al.
2007-05-31
C3b/C4b complement receptor-like molecules and uses thereof
App 20060287502 - Welcher; Andrew A. ;   et al.
2006-12-21
IL-17 receptor like molecules and uses thereof
Grant 7,094,566 - Medlock , et al. August 22, 2
2006-08-22
C3b/C4b Complement Receptor-like molecules and uses thereof
Grant 7,041,796 - Welcher , et al. May 9, 2
2006-05-09
Antibodies for IL-17 receptor like polypeptides and uses thereof
App 20060078967 - Medlock; Eugene ;   et al.
2006-04-13
IL-receptor like molecules and uses thereof
App 20060078933 - Medlock; Eugene ;   et al.
2006-04-13
IL-17 receptor like polypeptides and uses thereof
App 20060078966 - Medlock; Eugene ;   et al.
2006-04-13
C3b/C4b complement receptor-like molecules and uses thereof
App 20060030005 - Welcher; Andrew A. ;   et al.
2006-02-09
IL-17 like molecules and uses thereof
App 20050074427 - Medlock, Eugene ;   et al.
2005-04-07
Il-17 like molecules and uses thereof
App 20050048029 - Medlock, Eugene ;   et al.
2005-03-03
IL-17 like molecules and uses thereof
App 20050003451 - Medlock, Eugene ;   et al.
2005-01-06
C3b/C4b complement receptor-like molecules and uses thereof
Grant 6,656,707 - Welcher , et al. December 2, 2
2003-12-02
C3b/C4b complement receptor-like molecules and uses thereof
App 20020192758 - Welcher, Andrew A. ;   et al.
2002-12-19
C3b/C4b complement receptor-like molecules and uses thereof
App 20020151483 - Welcher, Andrew A. ;   et al.
2002-10-17
IL-17 like molecules and uses thereof
App 20020037524 - Medlock, Eugene ;   et al.
2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed